Acellular dermal matrix in eyelid surgery.
In 2008, the authors published data from a series of 69 patients (129 eyelids) who had been treated with EnduraGen during eyelid surgery. They have since gained experience with this material in an additional series of 19 patients, in whom the results have continued to be promising. In this article, the authors discuss some of the subtleties inherent in this procedure and present their surgical technique.